These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
576 related articles for article (PubMed ID: 3016504)
1. Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes. Werling LL; Brown SR; Puttfarcken P; Cox BM Mol Pharmacol; 1986 Aug; 30(2):90-5. PubMed ID: 3016504 [TBL] [Abstract][Full Text] [Related]
2. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes. Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503 [TBL] [Abstract][Full Text] [Related]
3. Multiple agonist-affinity states of opioid receptors: regulation of binding by guanyl nucleotides in guinea pig cortical, NG108-15, and 7315c cell membranes. Werling LL; Puttfarcken PS; Cox BM Mol Pharmacol; 1988 Apr; 33(4):423-31. PubMed ID: 2833686 [TBL] [Abstract][Full Text] [Related]
4. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus. Meunier JC; Kouakou Y; Puget A; Moisand C Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437 [TBL] [Abstract][Full Text] [Related]
5. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C. Werling LL; Zarr GD; Brown SR; Cox BM J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494 [TBL] [Abstract][Full Text] [Related]
6. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic. De Souza EB; Schmidt WK; Kuhar MJ J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773 [TBL] [Abstract][Full Text] [Related]
7. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes. Tam SW; Liu-Chen LY J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954 [TBL] [Abstract][Full Text] [Related]
8. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity. Su TP J Pharmacol Exp Ther; 1985 Jan; 232(1):144-8. PubMed ID: 2856939 [TBL] [Abstract][Full Text] [Related]
9. The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors. Hatzoglou A; Bakogeorgou E; Castanas E Eur J Pharmacol; 1996 Jan; 296(2):199-207. PubMed ID: 8838457 [TBL] [Abstract][Full Text] [Related]
10. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography. Morris BJ; Millan MJ; Herz A J Pharmacol Exp Ther; 1988 Nov; 247(2):729-36. PubMed ID: 2846828 [TBL] [Abstract][Full Text] [Related]
11. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors. Puttfarcken PS; Werling LL; Cox BM Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651 [TBL] [Abstract][Full Text] [Related]
12. [3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type. Garzón J; Sánchez-Blázquez P; Lee NM J Pharmacol Exp Ther; 1984 Oct; 231(1):33-7. PubMed ID: 6092603 [TBL] [Abstract][Full Text] [Related]
13. The direct demonstration of binding of mu, delta and kappa agonists to digitonin-solubilized opioid receptors from bovine striatum. Crema G; Gioannini TL; Hiller JM; Simon EJ NIDA Res Monogr; 1986; 75():9-12. PubMed ID: 2829015 [TBL] [Abstract][Full Text] [Related]
14. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes. Cruciani RA; Lutz RA; Munson PJ; Rodbard D J Pharmacol Exp Ther; 1987 Jul; 242(1):15-20. PubMed ID: 3039108 [TBL] [Abstract][Full Text] [Related]
15. Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Y cells. Kazmi SM; Mishra RK Mol Pharmacol; 1987 Jul; 32(1):109-18. PubMed ID: 3037297 [TBL] [Abstract][Full Text] [Related]
16. Binding to mu and delta opioid sites but not kappa sites is inhibited by Fab fragments from a monoclonal antibody directed against the opioid receptor. Bidlack JM NIDA Res Monogr; 1986; 75():21-4. PubMed ID: 2828974 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans. Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286 [TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of multiple kappa-opioid receptors by selective and nonselective ligand binding in guinea pig spinal cord: resolution of high and low affinity states of the kappa 2 receptors by a computerized model-fitting technique. Tiberi M; Magnan J Mol Pharmacol; 1990 May; 37(5):694-703. PubMed ID: 2160061 [TBL] [Abstract][Full Text] [Related]
19. Traumatic injury alters opiate receptor binding in rat spinal cord. Krumins SA; Faden AI Ann Neurol; 1986 May; 19(5):498-501. PubMed ID: 3013077 [TBL] [Abstract][Full Text] [Related]
20. Involvement of mu, delta and kappa receptors in morphine-induced tolerance in the guinea pig myenteric plexus. Leedham JA; Bennett LE; Taylor DA; Fleming WW J Pharmacol Exp Ther; 1991 Oct; 259(1):295-301. PubMed ID: 1656024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]